Altre lingue Exact Sciences Corporation

Azioni

EXAS

US30063P1057

Tempo reale stimato Cboe BZX Altri mercati azionari 17:46:00 16/04/2024			Variaz. 5gg	Var. 1 gen.
64,7 ^USD	-0,99%		-12,74%	-12,41%

15/04	Exact Sciences Corporation annuncia cambiamenti a livello esecutivo	CI
11/04	Exact Sciences firma un accordo di scambio del debito e di collocamento di note convertibili	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Sector Update: Health Care Stocks Advance Premarket Monday	15/04
Exact Sciences Names Aaron Bloomer CFO	15/04
Exact Sciences Names Aaron Bloomer as New Chief Financial Officer	15/04
Exact Sciences Appoints Aaron Bloomer as Chief Financial Officer, Effective from May 15, 2024	15/04
Exact Sciences Corporation Announces Executive Changes	15/04
Exact Sciences Signs Debt Exchange Deal, Placement of Convertible Notes	11/04
Exact Sciences Announces Debt Exchange Transaction and Private Placement of Convertible Senior Notes	11/04
Exact Sciences Corporation announced that it expects to receive $266.8 million in funding	10/04
Exact Sciences to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR Annual Meeting 2024	08/04
Exact Sciences Schedules First Quarter 2024 Earnings Call	08/04
Exact Sciences to Provide Mayo Clinic Patients with Individualized Cancer Tumor Information to Inform Treatment	04/04
Maverix Medical Closes Acquisition of Cirrus Bio as Foundation for Diagnostics Platform in Lung Cancer	01/04
Exact Sciences Advances Development of Non-Endoscopic Oncoguard® Esophagus Test to Screen for Esophageal Cancer and Pre-Cancer	28/03
Exact Sciences Corp. Advances Development of Non-Endoscopic Oncoguard Esophagus Test to Screen for Esophageal Cancer and Pre-Cancer	28/03
Exact Sciences Named 2024 Gallup Exceptional Workplace Award Winner	27/03
The New England Journal of Medicine Publishes Cologuard Plus™ Test Results from Pivotal BLUE-C Study	13/03
Exact Sciences and Basketball Great Jamal Mashburn Encourage Americans 45+ to Have a Game Plan Against Colon Cancer	07/03
Exact Sciences Insider Sold Shares Worth $287,500, According to a Recent SEC Filing	05/03
EXACT SCIENCES LAUNCHES RISKGUARD HEREDITARY CANCER TEST IN THE UNITED STATES	29/02
Exact Sciences Insider Sold Shares Worth $356,302, According to a Recent SEC Filing	29/02

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Exact Sciences Corporation

Azioni

EXAS

US30063P1057

Altre lingue

Filtri